natgillin/translations-raw huggingface dataset:
Corvi, R. et al.
Corvi, R. et al. (2008).
Mutagenesis, Vol 23/4, pp. 271-283.
Mutagenesis, Vol 23/4, str. 271.–283.
ILSI paper (draft).
ILSI paper (draft).
Mutation Research, Vol. 257/2, pp. 147-205.
Mutation Research, Vol. 257/2, str. 147.–205.
Mutation Research, Vol. 268/2, pp. 297-305.
Mutation Research, Vol. 268/2, str. 297.–305.
Brusick, D. (1986).
Brusick, D. (1986).
Environmental Mutagenesis, Vol. 8/6, pp. 789-886.
Environmental Mutagenesis, Vol. 8/6, str. 789.–886.
Mutation Research, Vol. 634/1-2, pp. 177-183.
Mutation Research, Vol. 634/1–2, str. 177.–183.
Environmental and Molecular Mutation., Vol. 49, pp. 439-452.
Environmental and Molecular Mutation., Vol. 49, str. 439.–452.
Mutation Research, Vol. 147/1-2, pp. 29-36.
Mutation Research, Vol. 147/1-2, str. 29.–36.
Fenech, M. (1997).
Fenech, M. (1997).
Mutation Research, Vol. 392, pp. 11-18.
Mutation Research, Vol. 392, str. 11.–18.
Payne, C.M. et al.
Payne, C.M. et al. (2010).
Nutrition and Cancer, Vol. 62/6, pp. 825-840.
Nutrition and Cancer, Vol. 62/6, str. 825.–840.
Bazin, E. et al.
Bazin, E. et al. (2010).
Environmental and Molecular Mutagenesis, Vol. 51/3, pp. 251-259.
Environmental and Molecular Mutagenesis, Vol. 51/3, str. 251.–259.
Le Hegarat, L. et al.
Le Hegarat, L. et al. (2010).
Mutagenesis, Vol. 25/6, pp. 555-560.
Mutagenesis, Vol. 25/6, str. 555.–560.
Josse, R. et al.
Josse, R. et al. (2012).
Mutagenesis, Vol. 27/3, pp. 295-304.
Mutagenesis, Vol. 27/3, str. 295.–304.
Ehrlich, V. et al.
Ehrlich, V. et al. (2002).
Mutagenesis, Vol. 17/3, pp. 257-260.
Mutagenesis, Vol. 17/3, str. 257.–260.
Knasmüller, S. et al.
Knasmüller, S. et al. (2004).
Toxicology, Vol. 198/1-3, pp. 315-328.
Toxicology, Vol. 198/1-3, str. 315.–328.
Gibson, D.P. et al.
Gibson, D.P. et al. (1997).
Mutation Research, Vol. 392/1-2, pp. 61-70.
Mutation Research, Vol. 392/1–2, str. 61.–70.
Bonassi, S. et al.
Bonassi, S. et al. (2001).
Environmental and Molecular Mutagenesis, Vol. 37/1, pp. 31-45.
Environmental and Molecular Mutagenesis, Vol. 37/1, str. 31.–45.
Mutation Research, Vol. 113/3-4, pp. 173-215.
Mutation Research, Vol. 113/3-4, str. 173.–215.
Journal of Environmental Pathology and Toxicology, Vol. 4/1, pp. 55-65.
Journal of Environmental Pathology and Toxicology, Vol. 4/1, str. 55.–65.
Elliott, B.M. et al.
Elliott, B.M. et al. (1992).
Mutagenesis, Vol. 7, pp. 175-177.
Mutagenesis, Vol. 7, str. 175.–177.
Johnson, T.E., D. R. Umbenhauer, S.M.
Johnson, T.E., D. R. Umbenhauer, S.M.
Environmental and Molecular Mutagenesis, Vol. 28, pp. 51-59.
Environmental and Molecular Mutagenesis, Vol. 28, str. 51.–59.
UNEP (2001).
UNEP (2001).
Mutation Research, Vol.190/3, pp. 225-8.
Mutation Research, Vol.190/3, str. 225–8.
Environmental Mutagenesis, Vol. 5/6, pp. 795-801.
Environmental Mutagenesis, Vol. 5/6, str. 795.–801.
Mutation Research, Vol. 652/2, pp. 122-130.
Mutation Research, Vol. 652/2, str. 122.–130.
Fenech, M. (1993).
Fenech, M. (1993).
Mutation Research, Vol. 285/1, pp. 35-44.
Mutation Research, Vol. 285/1, str. 35.–44.
Phelps, J.B., M.L.
Phelps, J.B., M.L.
Mutation Research, Vol. 521/1-2, pp. 103-112.
Mutation Research, Vol. 521/1-2, str. 103.–112.
Mutation Research, Vol. 655/1-2, pp. 1-3.
Mutation Research, Vol. 655/1-2, str. 1.–3.
Surralles, J. et al.
Surralles, J. et al. (1995).
Mutation Research, Vol. 341/3, pp. 169-184.
Mutation Research, Vol. 341/3, str. 169.–184.
Honma, M. (2011).
Honma, M. (2011).
Mutation Research, Vol. 724, pp. 86-87.
Mutation Research, Vol. 724, str. 86.–87.
Pfuhler, S. et al.
Pfuhler, S. et al. (2011).
Mutation Research, Vol. 723/2, pp. 101-107.
Mutation Research, Vol. 723/2, str. 101.–107.
OECD (2014).
OECD (2014).
Morita T., M. Honma, K. Morikawa (2012).
Morita T., M. Honma, K. Morikawa (2012).
Mutation Research, Vol. 741, pp. 32-56.
Mutation Research, Vol. 741, str. 32.–56.
Environmental and Molecular Mutagenesis, Vol. 54/1, pp. 36-43.
Environmental and Molecular Mutagenesis, Vol. 54/1, str. 36–43.
EPA, Office of Chemical Safety and Pollution Prevention (2011).
EPA, Office of Chemical Safety and Pollution Prevention (2011).
Sobol, Z. et al.
Sobol, Z. et al. (2012).
Mutation Research, Vol.746/1, pp. 29-34.
Mutation Research, Vol.746/1, str. 29.–34.
Mutation Research, Vol. 120/4, pp. 241-247.
Mutation Research, Vol. 120/4, str. 241.–247.
MacGregor, J. T., C.M.
MacGregor, J. T., C.M.
Mutation Research, Vol. 120/4, pp. 269-275.
Mutation Research, Vol. 120/4, str. 269.–275.
Bryce, S.M. et al.
Bryce, S.M. et al. (2011).
Environmental and Molecular Mutagenesis, Vol. 52/4, pp. 280–286.
Environmental and Molecular Mutagenesis, Vol. 52/4, str. 280.–286.
Environmental and Molecular Mutagenesis, Vol. 52/5, pp. 355–362.
Environmental and Molecular Mutagenesis, Vol. 52/5, str. 355.–362.
Shi, J., R. Bezabhie, A. Szkudlinska (2010).
Shi, J., R. Bezabhie, A. Szkudlinska (2010).
Mutagenesis, Vol. 25/1, pp. 33-40.
Mutagenesis, Vol. 25/1, str. 33.–40.
Fenech, M. et al.
Fenech, M. et al. (2003).
Mutation Research, Vol. 534/1-2, pp. 65-75.
Mutation Research, Vol. 534/1-2, str. 65.–75.
Elhajouji, A., M. Cunha, M. Kirsch-Volders (1998).
Elhajouji, A., M. Cunha, M. Kirsch-Volders (1998).
Mutagenesis, Vol. 13/2, pp. 193-8.
Mutagenesis, Vol. 13/2, str. 193–8.
Archives of Toxicology, Vol. 85/8, pp. 873-99.
Archives of Toxicology, Vol. 85/8, str. 873–99.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol.723/2, pp. 87-90.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol.723/2, str. 87.–90.
Ryan, T. P. (2000).
Ryan, T. P. (2000).
Hoffman, W.P., M.L.
Hoffman, W.P., M.L.
International Conference on Harmonisation (ICH) Guidance S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended For Human Use.
International Conference on Harmonisation (ICH) Guidance S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended For Human Use.
The level of reproducibility in predictions that can be expected from the test method is in the order of 85 % within laboratories and 80 % between laboratories (10).
Može se očekivati da će za predviđanja do kojih se dođe s pomoću ove ispitne metode stupanj obnovljivosti biti reda veličine 85 % unutar laboratorija i 80 % između laboratorija (10.).
Results generated in the validation study (18) and published studies (19) overall indicate that the accuracy of the DPRA in discriminating sensitisers (i.e. UN GHS/CLP Cat. 1) from non-sensitisers is 80 % (N=157) with a sensitivity of 80 % (88/109) and specificity of 77 % (37/48) when compared to LLNA results.
Rezultati dobiveni u validacijskoj studiji (18.) i objavljenim studijama (19.) općenito pokazuju da točnost metode DPRA u razlikovanju tvari koje izazivaju preosjetljivost (tj. onih iz kategorije 1. prema sustavu UN GHS / Uredbi o CLP-u) od tvari koje ne izazivaju preosjetljivost iznosi 80 % (N = 157) uz osjetljivost od 80 % (88/109) i specifičnost od 77 % (37/48) u usporedbi s rezultatima dobivenima metodom LLNA.
A test chemical should be soluble in an appropriate solvent at a final concentration of 100 mM (see paragraph 18).
Ispitivana kemikalija trebala bi biti topljiva u odgovarajućem otapalu pri konačnoj koncentraciji od 100 mM (vidjeti stavak 18.).
However, test chemicals that are not soluble at this concentration may still be tested at lower soluble concentrations.
Međutim, ispitivane kemikalije koje nisu topljive pri toj koncentraciji mogu se ispitati pri nižim koncentracijama pri kojima jesu topljive.
In such a case, a positive result could still be used to support the identification of the test chemical as a skin sensitiser but no firm conclusion on the lack of reactivity should be drawn from a negative result.
U tom se slučaju pozitivan rezultat može upotrijebiti kao potpora identifikaciji ispitivane kemikalije kao tvari koja izaziva preosjetljivost kože, ali se na temelju negativnog rezultata ne bi smio izvući čvrsti zaključak o nepostojanju reaktivnosti.
United Nations (UN) (2013).
United Nations (UN) (2013).
Adler et al.
Adler et al. (2011).
Gerberick et al.
Gerberick et al. (2004).
EC EURL-ECVAM (2013).
EC EURL-ECVAM (2013).
Jaworska et al.
Jaworska et al. (2013).
Bauch et al.
Bauch et al. (2012).
Nukada et al.
Nukada et al. (2013).
Ball et al (2011).
Ball et al (2011).
Landsteiner and Jacobs (1936).
Landsteiner and Jacobs (1936).
Dupuis and Benezra (1982).
Dupuis and Benezra (1982).
Lepoittevin et al.
Lepoittevin et al. (1998).
EC EURL ECVAM (2012).
EC EURL ECVAM (2012).
Natsch et al.
Natsch et al. (2013).
DB-ALM (INVITTOX) Protocol 154: Direct Peptide Reactivity assay (DPRA) for skin sensitisation testing 17pp.
DB-ALM (INVITTOX) Protocol 154: Direct Peptide Reactivity assay (DPRA) for skin sensitisation testing 17pp.
FDA (Food and Drug Administration (2001).
FDA (Food and Drug Administration (2001).
ECETOC (2003).
ECETOC (2003).
0-5,5
0-5.5
Adler S., Basketter D., Creton S., Pelkonen O., van Benthem J., Zuang V., Andersen K.E., Angers-Loustau A., Aptula A., Bal-Price A., Benfenati E., Bernauer U., Bessems J., Bois F.Y., Boobis A., Brandon E., Bremer S., Broschard T., Casati S., Coecke S., Corvi R., Cronin M., Daston G., Dekant W., Felter S., Grignard E., Gundert-Remy U., Heinonen T., Kimber I., Kleinjans J., Komulainen H., Kreiling R., Kreysa J., Leite S.B., Loizou G., Maxwell G., Mazzatorta P., Munn S., Pfuhler S., Phrakonkham P., Piersma A., Poth A., Prieto P., Repetto G., Rogiers V., Schoeters G., Schwarz M., Serafimova R., Tähti H., Testai E., van Delft J., van Loveren H., Vinken M., Worth A., Zaldivar J.M.
Adler S., Basketter D., Creton S., Pelkonen O., van Benthem J., Zuang V., Andersen K.E., Angers-Loustau A., Aptula A., Bal-Price A., Benfenati E., Bernauer U., Bessems J., Bois F.Y., Boobis A., Brandon E., Bremer S., Broschard T., Casati S., Coecke S., Corvi R., Cronin M., Daston G., Dekant W., Felter S., Grignard E., Gundert-Remy U., Heinonen T., Kimber I., Kleinjans J., Komulainen H., Kreiling R., Kreysa J., Leite S.B., Loizou G., Maxwell G., Mazzatorta P., Munn S., Pfuhler S., Phrakonkham P., Piersma A., Poth A., Prieto P., Repetto G., Rogiers V., Schoeters G., Schwarz M., Serafimova R., Tähti H., Testai E., van Delft J., van Loveren H., Vinken M., Worth A., Zaldivar J.M.
Archives of Toxicology 85, 367-485.
Archives of Toxicology 85, 367–485.
Natsch A. (2010).
Natsch A. (2010).
Toxicological Sciences 113, 284-292.
Toxicological Sciences 113, 284–292.
Emter R., Ellis G., Natsch A. (2010).
Emter R., Ellis G., Natsch A. (2010).
Toxicology and Applied Pharmacology 245, 281-290.
Toxicology and Applied Pharmacology 245, 281–290.
Dinkova-Kostova A.T., Holtzclaw W.D., Kensler T.W.
Dinkova-Kostova A.T., Holtzclaw W.D., Kensler T.W.
18, 1779-1791.
18, 1779–1791.
Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L.
Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L.
1(1), 45-49.
1(1), 45–49.
Natsch A., Bauch C., Foertsch L., Gerberick F., Normann K., Hilberer A., Inglis H., Landsiedel R., Onken S., Reuter H., Schepky A., Emter R. (2011).
Natsch A., Bauch C., Foertsch L., Gerberick F., Normann K., Hilberer A., Inglis H., Landsiedel R., Onken S., Reuter H., Schepky A., Emter R. (2011).
In Vitro 25, 733-744.
In Vitro 25, 733–744.
Natsch A., Ryan C.A., Foertsch L., Emter R., Jaworska J., Gerberick G.F., Kern P. (2013).
Natsch A., Ryan C.A., Foertsch L., Emter R., Jaworska J., Gerberick G.F., Kern P. (2013).
Journal of Applied Toxicology, 33, 1337-1352.
Journal of Applied Toxicology, 33, 1337–1352.
EURL-ECVAM (2014).
EURL-ECVAM (2014).
Natsch A., Emter R., Ellis G. (2009).
Natsch A., Emter R., Ellis G. (2009).
107, 106-121.
107, 106–121.
Ball N., Cagen S., Carrillo J.C., Certa H., Eigler D., Emter R., Faulhammer F., Garcia C., Graham C., Haux C., Kolle S.N., Kreiling R., Natsch A., Mehling A. (2011).
Ball N., Cagen S., Carrillo J.C., Certa H., Eigler D., Emter R., Faulhammer F., Garcia C., Graham C., Haux C., Kolle S.N., Kreiling R., Natsch A., Mehling A. (2011).
60, 389-400.
60, 389–400.
Bauch C., Kolle S.N., Ramirez T., Eltze T., Fabian E., Mehling A., Teubner W., van Ravenzwaay B., Landsiedel R. (2012).
Bauch C., Kolle S.N., Ramirez T., Eltze T., Fabian E., Mehling A., Teubner W., van Ravenzwaay B., Landsiedel R. (2012).
63, 489-504.
63, 489–504.
Jaworska J., Dancik Y., Kern P., Gerberick F., Natsch A. (2013).
Jaworska J., Dancik Y., Kern P., Gerberick F., Natsch A. (2013).
33, 1353-1364.
33, 1353–1364.
Andres E., Sa-Rocha V.M., Barrichello C., Haupt T., Ellis G., Natsch A. (2013).
Andres E., Sa-Rocha V.M., Barrichello C., Haupt T., Ellis G., Natsch A. (2013).
Toxicology In Vitro 27, 1220-1225.
Toxicology In Vitro 27, 1220–1225.
Fabian E., Vogel D., Blatz V., Ramirez T., Kolle S., Eltze T., van Ravenzwaay B., Oesch F., Landsiedel R. (2013).
Fabian E., Vogel D., Blatz V., Ramirez T., Kolle S., Eltze T., van Ravenzwaay B., Oesch F., Landsiedel R. (2013).
87, 1683-1969.
87, 1683–1969.
Thorne N., Inglese J., Auld D.S.
Thorne N., Inglese J., Auld D.S.
Chemistry and Biology 17, 646-657.
Chemistry and Biology 17, 646–657.
Gildea L.A., Ryan C.A., Foertsch L.M., Kennedy J.M., Dearman R.J., Kimber I., Gerberick G.F.
Gildea L.A., Ryan C.A., Foertsch L.M., Kennedy J.M., Dearman R.J., Kimber I., Gerberick G.F.
Dermatol., 126, 1813-1822.
Dermatol., 126, 1813–1822.
Ryan C.A., Gildea L.A., Hulette B.C., Dearman R.J., Kimber I., Gerberick G.F.
Ryan C.A., Gildea L.A., Hulette B.C., Dearman R.J., Kimber I., Gerberick G.F.
150, 301-316.
150, 301–316.
Toxicol. in vitro 27, 2225-2232.
Toxicol. in vitro 27, 2225–2232.
OECD (2015).
OECD (2015).
UN (2009), United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Third revised edition, New York & Geneva: United Nations Publications.
UN (2009), United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Third revised edition, New York & Geneva: United Nations Publications.
EC-ECVAM (2009), Statement on the scientific validity of cytotoxicity/cell-function based in vitro assays for eye irritation testing.
EC-ECVAM (2009), Statement on the scientific validity of cytotoxicity/cell-function based in vitro assays for eye irritation testing.
EC-ECVAM (1999), INVITOX Protocol 71: Fluorescein Leakage Test, Ispra, Italy: European Centre for the Validation of Alternative Methods (ECVAM).
EC-ECVAM (1999), INVITOX Protocol 71: Fluorescein Leakage Test, Ispra, Italy: European Centre for the Validation of Alternative Methods (ECVAM).
EC-ECVAM (2008), Fluorescein Leakage Assay Background Review Document as an Alternative Method for Eye Irritation Testing.
EC-ECVAM (2008), Fluorescein Leakage Assay Background Review Document as an Alternative Method for Eye Irritation Testing.
A chemical that produces a reversible change in the eye following application to the anterior surface of the eye; (b) Chemicals that are classified as UN GHS Categories 2A, or 2B; EU CLP Category 2; or U.S.
kemikalija koja nakon primjene na prednjoj površini oka dovodi do reverzibilne promjene u oku; (b) kemikalija koja je razvrstana kao tvar nadražujuća za oči u kategoriju 2.A ili 2.B sustava UN GHS, kategoriju 2. prema Uredbi EU-a o CLP-u ili kategoriju II. ili III.
EPA Categories II or III ocular irritants.
US EPA-e.
Data from other tissues e.g. stomach/duodenum/jejunum, blood etc. could be collected at the same time. The laboratory needs to demonstrate proficiency with each individual tissue in each species they are planning to study, and will need to demonstrate that an acceptable positive response with a known mutagen (e.g. EMS) can be obtained in that tissue.
Istodobno bi se mogli prikupiti i podaci za druga tkiva, npr. želudac/duodenum/jejunum, krv itd. Laboratorij treba dokazati osposobljenost na svakom tkivu svake vrste koju planira ispitivati te treba dokazati da se u tom tkivu može dobiti prihvatljiv pozitivni odgovor s poznatim mutagenom (npr. EMS-om).
Changes in clinical chemistry measures (e.g. AST, ALT), can also provide useful information on tissue damage and additional indicators such as caspase activation, TUNEL stain, Annexin V stain, etc. may also be considered. However, there are limited published data where the latter have been used for in vivo studies and some may be less reliable than others.
Promjene u parametrima kliničke kemije (npr. AST, ALT) mogu isto tako pružiti korisne informacije o oštećenju tkiva te se mogu razmotriti i dodatni pokazatelji poput aktivacije kaspaze, obilježavanja apoptotičkih stanica metodom TUNEL, obojenosti aneksinom V itd. Međutim, objavljeni podaci o upotrebi tih pokazatelja u istraživanjima in vivo ograničeni su i nisu svi jednako pouzdani.
Kirkland, D., G. Speit (2008), Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III.
Kirkland, D., G. Speit (2008), Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III.
Appropriate follow-up testing in vivo, Mutation Research, Vol. 654/2, pp. 114-32.
Appropriate follow-up testing in vivo, Mutation Research, Vol. 654/2, str. 114–32.
Burlinson, B. (2012), The in vitro and in vivo Comet assays, Methods in Molecular Biology, Vol. 817, pp. 143-63.
Burlinson, B. (2012), The in vitro and in vivo Comet assays, Methods in Molecular Biology, Vol. 817, str. 143.–63.
OECD (2014), Reports of the JaCVAM initiative international pre-validation and validation studies of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens, Series on Testing and Assessment, Nos. 195 and 196, OECD Publishing, Paris.
OECD (2014), Reports of the JaCVAM initiative international pre-validation and validation studies of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens, Series on Testing and Assessment, Nos. 195 and 196, OECD Publishing, Paris.
Olive, P.L., J.P.
Olive, P.L., J.P.
Tice, R.R., G.H.
Tice, R.R., G.H.
Strauss (1995), The single cell gel electrophoresis/Comet assay: a potential tool for detecting radiation-induced DNA damage in humans, Stem Cells, Vol. 13/1, pp. 207-14.
Strauss (1995), The single cell gel electrophoresis/Comet assay: a potential tool for detecting radiation-induced DNA damage in humans, Stem Cells, Vol. 13/1, str. 207.–14.
Collins, A.R (2004), The Comet assay for DNA damage and repair: principles, applications, and limitations, Molecular Biotechnology, Vol. 26/3, pp. 249-61.
Collins, A.R (2004), The Comet assay for DNA damage and repair: principles, applications, and limitations, Molecular Biotechnology, Vol. 26/3, str. 249.–61.
Vasquez, M.Z.
Vasquez, M.Z.
, Combining the in vivo Comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation, Mutagenesis, Vol. 25/2, pp. 187-99.
, Combining the in vivo Comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation, Mutagenesis, Vol. 25/2, str. 187.–99.
Bowen, D.E.
Bowen, D.E.
, Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test, Mutation Research, Vol. 722/1, pp. 7-19.
, Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test, Mutation Research, Vol. 722/1, str. 7.–19.
O'Donovan, M., B. Burlinson (2013), Maximum dose levels for the rodent comet assay to examine damage at the site of contact or to the gastrointestinal tract, Mutagenesis, Vol. 28/6, pp. 621-3.
O'Donovan, M., B. Burlinson (2013), Maximum dose levels for the rodent comet assay to examine damage at the site of contact or to the gastrointestinal tract, Mutagenesis, Vol. 28/6, str. 621.–3.
Hartmann, A. (2004), Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations, Mutagenesis, Vol. 19/1, pp. 51-9.
Hartmann, A. (2004), Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations, Mutagenesis, Vol. 19/1, str. 51.–9.
Nesslany, F. (2007), In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 630/1, pp. 28-41.
Nesslany, F. (2007), In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 630/1, str. 28.–41.
Brendler-Schwaab, S.Y., B.A.
Brendler-Schwaab, S.Y., B.A.
Herbold (1997), A new method for the enrichment of single renal proximal tubular cells and their first use in the Comet assay, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 393/1-2, pp. 175-8.
Herbold (1997), A new method for the enrichment of single renal proximal tubular cells and their first use in the Comet assay, Mutation Research/Genetic Toxicology and Environmental Mutagenesis,Vol. 393/1-2, str. 175.–8.
Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 627/1, pp. 31-5.
Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 627/1, str. 31.–5.
NTP Carcinogenicity Database, Critical Reviews in Toxicology, Vol. 30/6, pp. 629-799.
NTP Carcinogenicity Database, Critical Reviews in Toxicology, Vol. 30/6, str. 629.–799.
Speit, G, M. Vasquez, A. Hartmann (2009), The comet assay as an indicator test for germ cell genotoxicity, Mutation Research, Vol. 681/1, pp. 3-12.
Speit, G, M. Vasquez, A. Hartmann (2009), The comet assay as an indicator test for germ cell genotoxicity, Mutation Research, Vol. 681/1, str. 3.–12.
Zheng, H., P.L.
Zheng, H., P.L.
Olive (1997), Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice, International Journal of Radiation Biology, Vol. 71/3, pp. 275-282.
Olive (1997), Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice, International Journal of Radiation Biology, Vol. 71/3, str. 275.–282.
Pfuhler, S., H.U.
Pfuhler, S., H.U.
Wu, J.H., N.J.
Wu, J.H., N.J.
Jones (2012), Assessment of DNA interstrand crosslinks using the modified alkaline Comet assay, Methods in Molecular Biology, Vol. 817, pp. 165-81.
Jones (2012), Assessment of DNA interstrand crosslinks using the modified alkaline Comet assay, Methods in Molecular Biology, Vol. 817, str. 165.–81.
Spanswick, V.J., J.M.
Spanswick, V.J., J.M.
Hartley (2010), Measurement of DNA interstrand crosslinking in individual cells using the Single Cell Gel Electrophoresis (Comet) assay, Methods in Molecular Biology, Vol. 613, pp. 267-282.
Hartley (2010), Measurement of DNA interstrand crosslinking in individual cells using the Single Cell Gel Electrophoresis (Comet) assay, Methods in Molecular Biology, Vol. 613, str. 267.–282.
Kumaravel, T.S., A.N.
Kumaravel, T.S., A.N.
Jha (2006), Reliable Comet assay measurements for detecting DNA damage induced by ionizing radiation and chemicals, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 605(1-2), pp. 7-16.
Jha (2006), Reliable Comet assay measurements for detecting DNA damage induced by ionizing radiation and chemicals, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 605(1-2), str. 7.–16.
Ersson, C., L. Möller (2011), The effects on DNA migration of altering parameters in the Comet assay protocol such as agarose density, electrophoresis conditions and durations of the enzyme or the alkaline treatments, Mutagenesis, Vol. 26/6, pp. 689-95.
Ersson, C., L. Möller (2011), The effects on DNA migration of altering parameters in the Comet assay protocol such as agarose density, electrophoresis conditions and durations of the enzyme or the alkaline treatments, Mutagenesis, Vol. 26/6, str. 689.–95.
Ryan, T. P. (2000), Statistical Methods for Quality Improvement, John Wiley and Sons, New York 2nd ed.
Ryan, T. P. (2000), Statistical Methods for Quality Improvement, John Wiley and Sons, New York 2nd ed.